Juliet Gallagher

News

Assessment of Individual Risk for Epilepsy After CVT Using the DIAS3 Score

11/20/2024

The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.

The DIAS3 score, developed and...

11/20/2024

First Report Managed Care

News

Precision Phenotyping Algorithm Enhances Identification of Long COVID Cases

11/19/2024

Juliet Gallagher ;

Researchers have developed a precision phenotyping algorithm that improves the identification of long COVID and outperforms conventional diagnostic codes like U09.9.

Researchers have developed a...

11/19/2024

Integrated Healthcare Executive

News

FDA Proposes Removal of Oral Phenylephrine from OTC Nasal Decongestants

11/14/2024

Juliet Gallagher ;

The US Food and Drug Administration (FDA) has announced in a new press release that it is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) products for nasal decongestant, citing a lack of effectiveness.

The US Food and Drug...

11/14/2024

Pharmacy Learning Network

News

AI in Health Care Market to Grow to $148.4 Billion by 2029

11/14/2024

Juliet Gallagher ;

The health care artificial intelligence (AI) market is projected to grow rapidly, reaching $148.4 billion by 2029, driven by advancements in computing and applications across diagnostics, patient care, and personalized medicine.

The health care artificial...

11/14/2024

Integrated Healthcare Executive

News

Using Deep Learning to Measure MS-Specific Brain Damage Beyond Aging

11/11/2024

Juliet Gallagher ;

A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.

A new study published in...

11/11/2024

First Report Managed Care

News

Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance

11/08/2024

Juliet Gallagher ;

The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...

The Minnesota Department of...

11/08/2024

Pharmacy Learning Network

News

Clinical Predictors of One-Year Seizure Freedom After SLAH

11/06/2024

Juliet Gallagher ;

A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...

A study published in Annals of...

11/06/2024

First Report Managed Care

News

Advancing Personalized Treatment in Endometrial Cancer With the HECTOR Deep Learning Model

11/06/2024

Juliet Gallagher ;

According to a study published in Nature, endometrial cancer (EC) cases are on the rise, and 10% to 20% of patients with EC experience distant recurrence. In this study, in researchers aimed to predict distant recurrence of EC to improve...

According to a study published...

11/06/2024

Journal of Clinical Pathways

News

Improving COVID-19 Treatment Allocation With Machine Learning

11/05/2024

Juliet Gallagher ;

A retrospective cohort study published in JAMA Health Forum determined that a machine learning-based allocation method, specifically using policy learning trees, could improve the allocation of scarce COVID-19 treatments and reduce...

A retrospective cohort study...

11/05/2024

Integrated Healthcare Executive

News

FDA Grants Accelerated Approval for Asciminib as First-Line Treatment in Ph+CML-CP

11/01/2024

Juliet Gallagher ;

Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).

Novartis received accelerated...

11/01/2024

First Report Managed Care